Document is current
Any future updates will be listed below
-
Authors
Catarinella, Mario
Monestiroli, Andrea
Escobar, Giulia
Fiocchi, Amleto
Tran, Ngoc Lan
Aiolfi, Roberto
Marra, Paolo
Esposito, Antonio
Cipriani, Federica
Aldrighetti, Luca
Iannacone, Matteo
Naldini, Luigi
Guidotti, Luca G
Sitia, Giovanni
-
Funding
Funding for this research was provided by:
ERC (250219)
Ministero della Salute (GR‐2008‐1135776)
Ministero della Salute (GR‐2008‐1138756)
Ministero della Salute (RF‐2011‐02346754)
The San Raffaele International Postdoctoral Programme (PCOFUND‐GA‐2010‐267264)
- License Information
-
More Information
Article History
Received: 29 April 2015
Revised: 25 November 2015
Accepted: 4 December 2015
First Online: 14 January 2016
Conflict of interest
: LN is an inventor on patents describing microRNA‐regulated LVs owned by San Raffaele Scientific Institute and Telethon Foundation; LN is also a founder and owns equity in Genenta Science, a biotechnology startup aiming to develop targeted delivery of IFNα to hematopoietic tumors. The remaining authors declare that they have no conflict of interest.
